Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$226,401
-$20,144 QoQ
Shares Held
1,792
+1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,844
of 2,266 holders
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mystic Asset Management, Inc. holds $26,133,256 across 10 Drug Manufacturers - General names. GILD ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
28,377 | $7,206,906 | |
| 2 | ABBV |
AbbVie Inc.
|
20,254 | $5,096,716 | |
| 3 | PFE |
Pfizer Inc
|
178,085 | $4,288,286 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,899 | $2,942,521 | |
| 5 | LLY |
ELI LILLY & Co
|
2,274 | $2,727,504 | |
| 6 | NVS |
Novartis AG
|
9,069 | $1,421,293 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
21,037 | $1,212,151 | |
| 8 | NVO |
Novo Nordisk A S
|
11,400 | $546,516 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,401 | 1,792 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $246,545 | 1,769 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $206,080 | 1,679 | Shares | Sole | 2026-01-28 | |
| 2021-12-31 | $33,763 | 465 | Shares | Sole | 2022-02-23 | |
| No filing history on record for this holder in this stock. | ||||||